Tadashi Omoto

Eeffects of arteriovenous shunt on ventricular function in dog

BACKGROUND The bidirectional cavopulmonary shunt has been increasingly accepted as an interim step to the Fontan operation. However, the effect(s) of chronic volume overload on ventricular function are not yet well understood. METHODS Twelve mongrel dogs, with (chronic volume overload group), or without (control group) a femoral arteriovenous shunt created 8 weeks before the assessment, were subjected to a right heart bypass from the right atrium to the proximal pulmonary trunk. Nonpulsatile perfusion via the bypass was achieved using a centrifugal pump and cross-clamping of the pulmonary trunk. Left ventricular function was evaluated using the end-systolic elastance and the Doppler flow pattern on echocardiograms (epicardiac and transesophageal, simultaneously) during acute volume loading. RESULTS The left ventricular weight and the left ventricular weight/end-diastolic volume ratio showed no change from control values. The sum of the isovolumetric contraction time and the isovolumetric relaxation time divided by the ejection time remained constant during acute volume loading in the chronic volume overload group, while an increase was demonstrated in the control group. The chronic volume overload group showed a lower Ees (30.8 +/- 16.4 mmHg/cm2 vs. 107.6 +/- 70.3 mmHg/cm2, p = 0.03) than the control group. CONCLUSIONS The global ventricular performance changed with chronic adaptation to the arteriovenous shunt, and became resistant to acute volume loading. Left ventricular contractility under nonpulsatile pulmonary perfusion was impaired by chronic volume overload, which is deleterious to the Fontan operation.

The role of bidirectional cavopulmonary shunt on selection of Fontan patients

There are no objection against that pulmonary vascular resistance index (PVRI) is one of the most important factors for completion of successful application of Fontan-type operation. However, calculated PVRI in single ventricle physiology in often unreliable because of difficulty in accurate measurement of pulmonary blood flow, especially in patients with decreased pulmonary blood flow. Although the role of bidirectional cavopulmonary shunt (BCPS) in such patients has been increasingly recognized, the impact of BCPS on PVRI has not been fully understood. Between November 1993 and November 1996, 24 patients, aged between 0.54 and 22.2 years, with a wide variety of cardiac malformations underwent BCPS, and were followed up for the mean of 15.1 months. There were four hospital deaths (16.7%) and three deaths in follow-up (12.5%). Serial catheterization revealed that significant increase in mean arterial oxygen saturation from 75.8% to 83.9% (p = 0.005), and decrease in mean Nakatas index from 433 to 311 (p < 0.0001). PVRI calculated by using formulas derived from Ohms law before BCPS (Pulmonary flow was derived from Fick formula) was highly (greater than 10 u.m2) or moderately (between 4 and 10 u.m2) elevated in 6 and 7 patients, respectively. However, PVRI in these patients was normal after BCPS. Fourteen out of 24 patients underwent total cavopulmonary connection (TCPC) with 8 to 15 months of interval from BCPS, and have been currently surviving, and in NYHA functional class I or II, except 2 patients who underwent take-down. In conclusion, early and midterm outcome after staged operation appears to be excellent. BCPS is a good interim procedure, in part because one can more properly select patients undergoing Fontan operations from the PVRI point of view.

Near-infrared spectroscopy during hypothermic selective cerebral perfusion--a clinical study of its value

The purpose of this study is to assess the value of near-infrared spectroscopic oxymetry (NIRO) in monitoring cerebral oxygenation and metabolism during selective cerebral perfusion (SCP) for surgery of the aortic arch. The measurement protocol during SCP comprised oxyhemoglobin (HbO2), deoxyhemoglobin (Hb), and total hemoglobin levels in the brain. From March 1994 through March 1997, 14 patients underwent surgical treatment of the aortic arch anomalies with intraoperative monitoring with NIRO. The temporary circulatory arrest was accomplished at a rectal temperature of 22 degrees C and the hypothermic SCP was employed for the cerebral protection. SCP was initiated at a flow rate of 10 ml/kg/min so as to maintain HbO2 at the same level as immediately before the circulatory arrest (baseline). The longitudinal changes of HbO2 level during the process revealed four different patterns and were grouped accordingly. Three of the patients maintained HbO2 level above the baseline during SCP (Group A). HbO2 level reached to the baseline at initial flow rate but decreased gradually thereafter in 4 patients (Group B). Gradual increment of the perfusion flow rate failed to elevate HbO2 level to the baseline in the 5 patients (Group C1). In this group, HbO2 level started to elevate about 60 minutes after the initiation of SCP. HbO2 level of the remaining 2 patients was absolutely resistant to the increment of SCP flow rate and kept low values throughout SCP (Group C2). All the patients recovered uneventfully without any neurological abnormality. Our analyses for the longitudinal behavior of the HbO2 level confirmed the previously reported evidences that the values were affected not only by perfusion flow rate but also by hemodilution, blood transfusion, and perfusion pressure. Furthermore, our present study disclosed another evidence that HbO2 level was strongly affected by subclavian steal phenomenon. Although there were no differences in the clinical outcome among the groups, referring to the theories that HbO2 level is better not to be departed from baseline level, it could be concluded that HbO2 level monitoring in the setting of the determined hematocrit and hypothermia was effective for securing the adequate demand and supply balance of the cerebral oxygenation. Our conclusion may extend further that NIRO is a useful means in determining the optimal perfusion flow rate of SCP during surgery of the aortic arch.

Evaluation and Coil Embolization of the Aortic Side Branches for Prevention of Type II Endoleak after Endovascular Repair of Abdominal Aortic Aneurysm

Objectives: Aneurysm shrinkage after EVAR is the strong factor of favorable outcomes after endovascular abdominal aortic aneurysm repair (EVAR), and type II endoleaks is the risk factor of no aneurysm shrinkage or aneurysm enlargement in the long term. In this study, we evaluate the aortic side branches relate to early postoperative type II endoleak, and performed coil embolization for those vessels for prevention of type II endoleak. Methods: Patency and diameter of aortic side branches including inferior mesenteric artery (IMA) and lumbar artery (LA) were evaluated in 56 consecutive patients with abdominal aortic aneurysm who were scheduled for EVAR. Coil embolization with Interlock was performed in 24 patients during EVAR for all patent IMA and LA with maximal diameter more than 2.0 mm. Computed tomography was performed one week after EVAR for evaluation of endoleak. Results: In patients with IMA more than 2.5 mm in diameter, the frequency of type II endoleak was approximately 90% regardless of the number of patent LA. In case with patent IMA less than 2.5 mm or with 2 or more patent LA larger than 2.0 mm, the frequency of type II endoleak was 46 to 67%. Coil embolization for IMA was successfully performed in 15/16 patients (94%). Coil embolization of LA was performed for patent LA larger than 2.0 mm and 29 out of 45 LA (64%) were successfully occluded. There was no perioperative complication associated with coil embolization. The frequency of type II endoleak was significantly lower in patients with coil embolization than those without coil embolization (4.2% vs 58.9%, p<0.0001). Conclusion: Patent IMA and LA in diameter larger than 2.0 mm were associated with type II endoleak one week after EVAR, and coil embolization with Interlock during EVAR is safe and effective procedure to prevent type II endoleak. (This is a translation of Jpn J Vasc Surg 2016; 25: 321–328.)

The surgical treatment of fixed subaortic stenosis: a clinical experience in Japan.

We report herein the results of a retrospective study conducted on ten consecutive Japanese patients who underwent successful surgical relief of fixed subaortic stenosis between 1972 and 1994 at ages ranging from 8 months to 21 years, and followed for 3.6 years and 26 years. Associated cardiovascular defects were present in six patients, two had a history of infective endocarditis, a discrete fibrous ring was found in nine patients, and a redundant abnormal sheet was found in one. A stenotic structure was removed in nine patients and incised in one, while myotomy was additionally performed in one. There were no early complications or deaths. Cardiac catheterization revealed a significant decrease in the peak systolic pressure gradient from 84±22 mmHg preoperatively to 32±22 mmHg postoperatively (P=0.0017). Reoperation of an aortic valve replacement with or without valvular annulus enlargement was required in four patients because of a small annulus with aortic insufficiency or infective endocarditis. Infective endocarditis was a major cause of late mortality (n=1) and morbidity (n=1), but the remaining eight patients have been asymptomatic. Thus, although this lesion is relatively rare in Japan, the typical discrete type may be more common than previously believed. While a relief operation is associated with low early mortality, the palliative aspect regarding pathology of the aortic valve should not be underestimated, including poor growth of the valve annulus, deterioration of aortic insufficiency, and infective endocarditis. The most appropriate operative procedure for reoperation remains to be evolved.

The Combined Use of Extra-Aortic Balloon Counterpulsation and a Ventricular Assist Cup for Acute Heart Failure in Dogs — Effects on Regional Blood Flow

We evaluated the applicability and effectiveness of support with a combination of an extra-aortic balloon (EAB) and a ventricular assist cup (VAC), using an acute heart failure model. Under general anesthesia, ten adult dogs were used. Through median sternotomy, an EAB was placed around the ascending aorta and a VAC in the pericardial cavity. After heart failure was induced by the administration of propranolol, on-off tests of devices were performed as follows: EAB only; VAC only; and both devices in operation. Regional blood flows (RBFs) in both ventricles and in the liver, kidney, and brain were measured using a colored microsphere technique. Aortic flow and cardiac output were also measured. In the heart failure model, aortic flow and cardiac output decreased to 65% and 66% of the control value, respectively. With assistance by the EAB only, RBFs in both ventricle and brain increased significantly. With only the VAC on, RBFs in all but the left ventricle significantly increased. With both the EAB and the VAC on, all five RBFs significantly increased. These results suggest that the combination of EAB and VAC is applicable and effective, and would be a very promising implantable device for chronic heart failure.